ChemoCentryx Current Ratio 2009-2020 | CCXI

ChemoCentryx current ratio from 2009 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ChemoCentryx Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.47B $0.05B 10.12
2020-06-30 $0.51B $0.06B 9.00
2020-03-31 $0.19B $0.06B 3.22
2019-12-31 $0.17B $0.06B 2.95
2019-09-30 $0.17B $0.06B 3.12
2019-06-30 $0.20B $0.06B 3.57
2019-03-31 $0.23B $0.07B 3.43
2018-12-31 $0.18B $0.06B 2.82
2018-09-30 $0.18B $0.06B 2.87
2018-06-30 $0.19B $0.07B 2.69
2018-03-31 $0.15B $0.08B 1.96
2017-12-31 $0.18B $0.03B 5.46
2017-09-30 $0.12B $0.04B 2.76
2017-06-30 $0.12B $0.05B 2.78
2017-03-31 $0.12B $0.04B 2.82
2016-12-31 $0.15B $0.04B 3.88
2016-09-30 $0.12B $0.03B 4.68
2016-06-30 $0.13B $0.02B 5.54
2016-03-31 $0.07B $0.01B 8.82
2015-12-31 $0.07B $0.01B 13.11
2015-09-30 $0.07B $0.01B 13.40
2015-06-30 $0.07B $0.01B 13.62
2015-03-31 $0.08B $0.01B 9.82
2014-12-31 $0.07B $0.01B 9.08
2014-09-30 $0.09B $0.01B 10.59
2014-06-30 $0.10B $0.01B 12.72
2014-03-31 $0.13B $0.01B 18.88
2013-12-31 $0.13B $0.01B 19.54
2013-09-30 $0.13B $0.01B 19.37
2013-06-30 $0.13B $0.01B 15.08
2013-03-31 $0.08B $0.01B 8.29
2012-12-31 $0.10B $0.01B 9.25
2012-09-30 $0.13B $0.01B 10.88
2012-06-30 $0.13B $0.01B 11.61
2012-03-31 $0.12B $0.01B 12.04
2011-12-31 $0.09B $0.01B 9.76
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $0.10B $0.01B 7.97
2009-12-31 $0.09B $0.01B 6.49
2008-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.457B $0.036B
ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.626B 42.31
Takeda Pharmaceutical (TAK) Japan $57.159B 10.66
Astellas Pharma (ALPMY) Japan $30.180B 18.85
Eisai (ESALY) Japan $21.878B 19.06
Catalent (CTLT) United States $19.240B 57.55
Grifols, S.A (GRFS) Spain $13.098B 15.00
Neurocrine Biosciences (NBIX) United States $10.923B 85.96
Jazz Pharmaceuticals (JAZZ) Ireland $9.396B 15.18
Ionis Pharmaceuticals (IONS) United States $8.634B 84.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.530B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.433B 0.00
United Therapeutics (UTHR) United States $7.453B 15.87
IPSEN SA ADR (IPSEY) France $7.292B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.943B 402.83
Sage Therapeutics (SAGE) United States $4.609B 0.00
FibroGen (FGEN) United States $4.328B 0.00
PTC Therapeutics (PTCT) United States $4.323B 0.00
Hypermarcas (HYPMY) Brazil $4.041B 14.84
Cronos Group (CRON) Canada $3.789B 0.00
Corcept Therapeutics (CORT) United States $3.260B 31.53
Nektar Therapeutics (NKTR) United States $2.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.951B 15.06
Pacira BioSciences (PCRX) United States $2.948B 64.02
Revolution Medicines (RVMD) United States $2.866B 0.00
Xencor (XNCR) United States $2.787B 0.00
Tilray (TLRY) Canada $2.406B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.881B 0.00
USANA Health Sciences (USNA) United States $1.823B 16.05
Translate Bio (TBIO) United States $1.712B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.655B 14.16
BioCryst Pharmaceuticals (BCRX) United States $1.626B 0.00
Heron Therapeutics (HRTX) United States $1.609B 0.00
Endo (ENDP) Ireland $1.596B 2.42
Ocular Therapeutix (OCUL) United States $1.520B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.490B 10.35
ImmunoGen (IMGN) United States $1.437B 0.00
Trillium Therapeutics (TRIL) Canada $1.328B 0.00
Indivior (INVVY) United States $1.313B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.160B 0.00
ORGANOGENESIS (ORGO) United States $1.139B 0.00
Karyopharm Therapeutics (KPTI) United States $1.111B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
Radius Health (RDUS) United States $1.010B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.957B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.828B 48.84
Calliditas Therapeutics AB (CALT) Sweden $0.789B 0.00
Aerie Pharmaceuticals (AERI) United States $0.787B 0.00
Aclaris Therapeutics (ACRS) United States $0.782B 0.00
VAXART, INC (VXRT) United States $0.782B 0.00
Esperion Therapeutics (ESPR) United States $0.723B 0.00
Acutus Medical (AFIB) United States $0.723B 0.00
Ardelyx (ARDX) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Chinook Therapeutics (KDNY) United States $0.634B 0.00
Molecular Templates (MTEM) United States $0.602B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.582B 0.00
Flexion Therapeutics (FLXN) United States $0.569B 0.00
Harpoon Therapeutics (HARP) United States $0.551B 0.00
Siga Technologies (SIGA) United States $0.543B 15.26
PROFOUND MEDICL (PROF) Canada $0.509B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.501B 0.00
Jounce Therapeutics (JNCE) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.486B 0.00
Altimmune (ALT) United States $0.475B 0.00
Summit Therapeutics (SMMT) United States $0.462B 0.00
DURECT (DRRX) United States $0.457B 0.00
Sundial Growers (SNDL) Canada $0.456B 0.00
TherapeuticsMD (TXMD) United States $0.450B 0.00
CASI Pharmaceuticals (CASI) United States $0.420B 0.00
Rafael Holdings (RFL) United States $0.412B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.393B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.373B 9.73
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.336B 0.00
Concert Pharmaceuticals (CNCE) United States $0.331B 0.00
Nature's Sunshine Products (NATR) United States $0.317B 20.44
Menlo Therapeutics (VYNE) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.312B 0.00
KalVista Pharmaceuticals (KALV) United States $0.289B 0.00
Redhill Biopharma (RDHL) Israel $0.286B 0.00
Lannett Co Inc (LCI) United States $0.281B 7.40
Infinity Pharmaceuticals (INFI) United States $0.263B 0.00
Xeris Pharmaceuticals (XERS) United States $0.262B 0.00
Jaguar Animal Health (JAGX) United States $0.261B 0.00
CTI BioPharma (CTIC) United States $0.254B 0.00
IMV INC (IMV) Canada $0.247B 0.00
Otonomy (OTIC) United States $0.238B 0.00
Calithera Biosciences (CALA) United States $0.219B 0.00
Oncternal Therapeutics (ONCT) United States $0.215B 0.00
OptiNose (OPTN) United States $0.214B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.203B 0.00
Novan (NOVN) United States $0.191B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.177B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.168B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.151B 0.00
ProPhase Labs (PRPH) United States $0.148B 0.00
Onconova Therapeutics (ONTX) United States $0.147B 0.00
Lipocine (LPCN) United States $0.146B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.123B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.122B 0.00
ElectroCore (ECOR) United States $0.121B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
SCYNEXIS (SCYX) United States $0.089B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Recro Pharma (REPH) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.084B 161.83
Biomerica (BMRA) United States $0.082B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.077B 0.00
CV Sciences (CVSI) United States $0.070B 0.00
Vical (BBI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.066B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.056B 0.00
Regulus Therapeutics (RGLS) United States $0.051B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.38
Neos Therapeutics (NEOS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.91
Opiant Pharmaceuticals (OPNT) United States $0.040B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Flex Pharma (SLRX) United States $0.030B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Cyanotech (CYAN) United States $0.021B 34.90
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00